ReviewJournal of immunotherapy and precision oncology2026
Class II Major Histocompatibility Complex Transactivator (CIITA): A Master MHC-II Regulator Impacting Cancer and Beyond.
Soon Khai Low et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.